Federal contract award
75F40125C00063
THE PURPOSE OF THIS CONTRACT IS TO CONDUCT RESEARCH AND DEVELOP TOOLS TO STRENGTHEN POST-MARKET SURVEILLANCE OF FDA-REGULATED PRODUCTS. THE OBJECTIVE IS TO APPLY ADVANCED ANALYTICS AND HYBRID ARTIFICIAL INTELLIGENCE TO IMPROVE RISK IDENTIFICATION USI
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AJ11 — GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $515.8K |
| Current contract value | $515.8K |
| Potential contract value / ceiling | $515.8K |
| Start date | Sep 8, 2025 |
| Current end date | Sep 29, 2026 |
| Potential end date | Sep 29, 2026 |
| Latest award activity | Sep 8, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 8, 2025 | 0 | $515.8K | THE PURPOSE OF THIS CONTRACT IS TO CONDUCT RESEARCH AND DEVELOP TOOLS TO STRENGTHEN POST-MARKET SURVEILLANCE OF FDA-REGULATED PRODUCTS. THE OBJECTIVE IS TO APPLY ADVANCED ANALYTICS AND HYBRID ARTIFICIAL INTELLIGENCE TO IMPROVE RISK IDENTIFICATION USI |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.